↑Beuschlein F, Fassnacht M, Klink A, Allolio B, Reincke M (2001). „ACTH-receptor expression, regulation and role in adrenocortial tumor formation”. Eur. J. Endocrinol.144 (3): 199–206. DOI:10.1530/eje.0.1440199. PMID11248736.
↑Elias LLK, Clark AJL (2000). „The expression of the ACTH receptor”. Brazilian Journal of Medical and Biological Research33 (10): 1245–1248. DOI:10.1590/S0100-879X2000001000015. PMID11004726.
↑Clark AJL, McLoughlin L, Grossman A (October 1993). „Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor”. Lancet341 (8843): 461–462. DOI:10.1016/0140-6736(93)90208-X. PMID8094489.
Allolio B, Reincke M (1997). „Adrenocorticotropin receptor and adrenal disorders.”. Horm. Res.47 (4-6): 273–8. DOI:10.1159/000185476. PMID9167964.
Tatro JB (1997). „Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides.”. Neuroimmunomodulation3 (5): 259–84. DOI:10.1159/000097281. PMID9218248.
Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992). „The cloning of a family of genes that encode the melanocortin receptors.”. Science257 (5074): 1248–51. DOI:10.1126/science.1325670. PMID1325670.
Clark AJ, McLoughlin L, Grossman A (1993). „Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor.”. Lancet341 (8843): 461–2. DOI:10.1016/0140-6736(93)90208-X. PMID8094489.
Gantz I, Tashiro T, Barcroft C, et al. (1994). „Localization of the genes encoding the melanocortin-2 (adrenocorticotropic hormone) and melanocortin-3 receptors to chromosomes 18p11.2 and 20q13.2-q13.3 by fluorescence in situ hybridization.”. Genomics18 (1): 166–7. DOI:10.1006/geno.1993.1448. PMID8276410.
Gantz I, Konda Y, Tashiro T, et al. (1993). „Molecular cloning of a novel melanocortin receptor.”. J. Biol. Chem.268 (11): 8246–50. PMID8463333.
Naville D, Barjhoux L, Jaillard C, et al. (1996). „Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency.”. J. Clin. Endocrinol. Metab.81 (4): 1442–8. DOI:10.1210/jc.81.4.1442. PMID8636348.
Naville D, Jaillard C, Barjhoux L, et al. (1997). „Genomic structure and promoter characterization of the human ACTH receptor gene.”. Biochem. Biophys. Res. Commun.230 (1): 7–12. DOI:10.1006/bbrc.1996.5911. PMID9020063.
Yang YK, Ollmann MM, Wilson BD, et al. (1997). „Effects of recombinant agouti-signaling protein on melanocortin action.”. Mol. Endocrinol.11 (3): 274–80. DOI:10.1210/me.11.3.274. PMID9058374.
Penhoat A, Naville D, Jaillard C, et al. (1997). „Presence of multiple functional polyadenylation signals in the 3'-untranslated region of human corticotropin receptor cDNA.”. Biochim. Biophys. Acta1356 (3): 249–52. DOI:10.1016/S0167-4889(97)00031-1. PMID9194567.
Flück CE, Martens JW, Conte FA, Miller WL (2002). „Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay.”. J. Clin. Endocrinol. Metab.87 (9): 4318–23. DOI:10.1210/jc.2002-020501. PMID12213892.
Swords FM, Baig A, Malchoff DM, et al. (2003). „Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity.”. Mol. Endocrinol.16 (12): 2746–53. DOI:10.1210/me.2002-0099. PMID12456795.
„Melanocortin Receptors: MC2”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Arhivirano iz originala na datum 2016-03-03.